齐翔腾达9月30日获融资买入537.92万元，融资余额4.01亿元

Core Viewpoint - Qixiang Tengda's stock performance shows a decline in trading volume and financing activities, indicating potential liquidity issues and reduced investor interest [1][2]. Financing Summary - On September 30, Qixiang Tengda experienced a financing buy-in of 5.38 million yuan, with a net financing outflow of 4.27 million yuan, resulting in a total financing balance of 403 million yuan [1]. - The current financing balance represents 2.93% of the circulating market value, which is below the 10% percentile level over the past year, indicating a low financing level [1]. - The company also saw a securities lending repayment of 11,900 shares and a securities lending sell-out of 1,400 shares, with a total lending balance of 1.76 million yuan, also below the 20% percentile level over the past year [1]. Business Performance Summary - For the first half of 2025, Qixiang Tengda reported a revenue of 12.21 billion yuan, a year-on-year decrease of 4.09%, and a net profit attributable to shareholders of 23.15 million yuan, down 83.34% year-on-year [2]. - The company's main business revenue composition includes 42.93% from maleic anhydride, 35.28% from foreign trade, 10.72% from other chemicals, 8.96% from acetone, and 2.12% from other sources [1]. Shareholder and Dividend Information - Since its A-share listing, Qixiang Tengda has distributed a total of 2.64 billion yuan in dividends, with 908 million yuan distributed over the past three years [3]. - As of June 30, 2025, the number of shareholders decreased to 56,400, while the average circulating shares per person increased by 5.83% to 48,740 shares [2][3]. - Notable changes in institutional holdings include Hong Kong Central Clearing Limited as the fourth-largest shareholder, reducing its stake by 3.59 million shares, while new entrants include Southern CSI 1000 ETF and Huaxia CSI 1000 ETF [3].